Heparin prevents formation of the human C3 amplification convertase by inhibiting the binding site for B on C3bMAILLET, F; KAZATCHKINE, M. D; GLOTZ, D et al.Molecular immunology. 1983, Vol 20, Num 12, pp 1401-1404, issn 0161-5890Article

Reduction of the β-Cys-γ-Glu thiol ester bond of human C3 with sodium borohydrideTHOMAS, M. L; DAVIDSON, F. F; TACK, B. F et al.The Journal of biological chemistry (Print). 1983, Vol 258, Num 22, pp 13580-13586, issn 0021-9258Article

ACTIVITY OF THE ALTERNATIVE PATHWAY OF COMPLEMENT IN THE NEWBORN INFANTADAMKIN D; STITZEL A; URMSON J et al.1978; J. PEDIATR.; USA; DA. 1978; VOL. 93; NO 4; PP. 604-608; BIBL. 24 REF.Article

ISOLATION AND CHARACTERIZATION OF RAT COMPLEMENT FACTOR B AND ITS INTERACTION WITH CELL-BOUND HUMAN C3DAHA MR; VAN ES LA.1980; IMMUNOLOGY; ISSN 0019-2805; GBR; DA. 1980; VOL. 41; NO 4; PP. 849-855; BIBL. 20 REF.Article

FORMATION IN THE PRESENCE OF C3 NEPHRITIC FACTOR (C3NEF) OF AN ALTERNATIVE PATHWAY C3 CONVERTASE CONTAINING UNCLEAVED B.DAHA MR; FEARON DT; AUSTEN KF et al.1976; IMMUNOLOGY; G.B.; DA. 1976; VOL. 31; NO 5; PP. 789-795; BIBL. 1 P.Article

Synthesis of complement components C3 and factor B in human keratinocytes is differentially regulated by cytokinesPASCH, M. C; VAN DEN BOSCH, N. H. A; DAHA, M. R et al.Journal of investigative dermatology. 2000, Vol 114, Num 1, pp 78-82, issn 0022-202XConference Paper

Effects of UVB on the synthesis of complement proteins by keratinocytesPASCH, M. C; OKADA, N; BOS, J. D et al.Journal of investigative dermatology. 1998, Vol 111, Num 4, pp 683-688, issn 0022-202XArticle

Carbohydrate composition of the second, third and fifth components and factors B and D of human complementTOMANA, M; NIEMANN, M; GARNER, C et al.Molecular immunology. 1985, Vol 22, Num 2, pp 107-111, issn 0161-5890Article

Generation of three different fragments of bound C3 with purified factor I or serum. II: Location of linding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutininROSS, G. D; NEWMAN, S. L; LAMBRIS, J. D et al.The Journal of experimental medicine. 1983, Vol 158, Num 2, pp 334-352, issn 0022-1007Article

GINGIVAL FLUID ANS SERUM IN PERIODANTAL DISEASES. II. EVIDENCE FOR CLEAVAGE OF COMPLEMENT COMPONENTS C₃, C₃ PROACTIVATOR (FACTOR B) AND C₄ IN GINGIVAL FLUID.SCHENKEIN HA; GENCO RJ.1977; J. PERIODONTOL.; U.S.A.; DA. 1977; VOL. 48; NO 12; PP. 778-784; BIBL. 34 REF.Article

FACTEURS DU COMPLEMENT DANS LE LUPUS ERYTHEMATEUX DISSEMINE.RODRIGO J; GUARDIA J; CABRE VERDIELL J et al.1977; LYON MED.; FR.; DA. 1977; VOL. 238; NO 17; PP. 303-305; ABS. ANGL.; BIBL. 7 REF.Article

KOMPLEMENTSPIEGEL BEI KINDERN MIT IDIOPATHISCH-NEPHROTISCHEM SYNDROM. (C3, C4 UND C3-AKTIVATOR). = LE TAUX DU COMPLEMENT CHEZ LES ENFANTS PRESENTANT UN SYNDROME NEPHROTIQUE IDIOPATHIQUE (C₃, C₄ ET ACTIVATEUR C₃)POLZ E; LUBEC G.1977; PAEDIATR. U. PAEDOL.; OESTERR.; DA. 1977; VOL. 12; NO 4; PP. 360-364; ABS. ANGL.; BIBL. 12 REF.Article

CLINICAL APPLICATIONS OF IMMUNOFIXATION: DETECTION AND QUANTITATION OF COMPLEMENT ACTIVATIONWHICHER JT; HIGGINSON J; RICHES PG et al.1980; J. CLIN. PATHOL.; ISSN 0021-9746; USA; DA. 1980; VOL. 33; NO 8; PP. 781-785; BIBL. 19 REF.Article

LES SCLEROSES EN PLAQUES AVEC HYPOCOMPLEMENTEMIE. 26 OBSERVATIONS.TROUILLAS P; MOINDROT J; AIMARD G et al.1976; LYON MED.; FR.; DA. 1976; VOL. 235; NO 10; PP. 853-859; ABS. ANGL.; BIBL. 1 P. 1/2Article

AKTIVIERTES C3 IN DER SYNOVIAL FLUESSIGKEIT VON PATIENTEN MIT RHEUMATOIDER ARTHRITIS UND ARTHROSE (KORRELATIONEN MIT C3, C4 UND C3-PROAKTIVATOR (BEEINFLUSSUNG DURCH LAGERUNG) = C₃ ACTIVE DANS LE LIQUIDE SYNOVIAL DES MALADES AVEC POLYARTHRITE RHUMATOIDE ET ARTHROSE (CORRELATION AVEC C₃, C₄ ET C₃-PROACTIVATEUR. INFLUENCE DE LA CONSERVATION)HASLER F; STOJAN B.1981; Z. RHEUMATOL.; ISSN 0340-1855; DEU; DA. 1981; VOL. 40; NO 1; PP. 40-43; ABS. ENG; BIBL. 19 REF.Article

SYNTHESIS OF FACTORS D, B AND P OF THE ALTERNATIVE PATHWAY OF COMPLEMENT ACTIVATION, AS WELL AS OF C3, BY GUINEA-PIG PERITONEAL MACROPHAGES IN VITROBENTLEY C; FRIES W; BRADE V et al.1978; IMMUNOLOGY; GBR; DA. 1978; VOL. 35; NO 6; PP. 971-980; BIBL. 24 REF.Article

Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitatesTAKATA, Y; TAMURA, N; FUJITA, T et al.The Journal of immunology (1950). 1984, Vol 132, Num 5, pp 2531-2537, issn 0022-1767Article

Comparison of binding characteristics of factors B and H to C3B on normal and paroxysmal nocturnal hemoglobinuria erythrocytesPARKER, C. J; BAKER, P. J; ROSSE, W. F et al.The Journal of immunology (1950). 1983, Vol 131, Num 5, pp 2484-2489, issn 0022-1767Article

REPRODUCIBLE IN VITRO PREPARATION OF INTERMEDIATE C3D COATED RED BLOOD CELLSHOFFMAN NL; MONROE MC; CHAPLIN H JR et al.1982; TRANSFUSION (PHILA.); ISSN 0041-1132; USA; DA. 1982; VOL. 22; NO 3; PP. 180-184; BIBL. 7 REF.Article

INACTIVATOR OF THE THIRD COMPONENT OF COMPLEMENT AS AN INHIBITOR IN THE PROPERDIN PATHWAYALPER CA; ROSEN FS; LACHMANN PJ et al.1972; PROC. NATION. ACAD. SCI. U.S.A.; U.S.A.; DA. 1972; VOL. 69; NO 10; PP. 2910-2913; BIBL. 20 REF.Serial Issue

An unusual Morphologic variant of BP SRAUM, D; SURGENOR, T; AWDEH, Z et al.American journal of human genetics. 1984, Vol 36, Num 2, pp 346-351, issn 0002-9297Article

POLYMORPHISM OF THE THIRD COMPONENT OF HUMAN COMPLEMENTDAVRINCHE C; RIVAT C.1982; REV. FR. TRANSFUS. IMMUNOHEMATOL.; ISSN 0338-4535; FRA; DA. 1982; VOL. 25; NO 2; PP. 199-213; ABS. FRE; BIBL. 77 REF.Article

B-CELL LYMPHOMA LACKING FC- AND C3D-RECEPTORSTHIEL E.1978; BLUT; DEU; DA. 1978; VOL. 37; NO 6; PP. 307-312; ABS. GER; BIBL. 23 REF.Article

THE INCORPORATION OF C3 NEPHRITIC FACTOR (C3NEF) INTO A STABILIZED C3 CONVERTASE, C3BBB (C3NEF), AND ITS RELEASE AFTER DECAY OF CONVERTASE FUNCTION.DAHA MR; AUSTEN KF; FEARON DT et al.1977; J. IMMUNOL.; U.S.A.; DA. 1977; VOL. 119; NO 3; PP. 812-817; BIBL. 19 REF.Article

GENETIC POLYMORPHISM OF HUMAN COMPLEMENT PROTEINSHAUPTMANN G.1979; REV. FR. TRANSFUS. IMMUNO. HEMATOL.; FRA; DA. 1979; VOL. 22; NO 5; PP. 587-614; ABS. FRE; BIBL. 107 REF.Article